speb/financial-data huggingface dataset:
Financial ratios for APARINDS.NS — annual report dated 2023-03-31
Total revenue: 1736643118.1485994
Gross profit: 378848964.6772229
Operating income: 147450669.91473815
Net income: 77676004.8721072
Capital expenditures: 30048721.071863584
Operating cash flow: 85059683.3130329
Depreciation & amortization: 12708891.595615104
Net tangible assets: 272188794.1534714
Owner earnings: 60336175.39585871
Return on net tangible assets (%): 22.167031373759883
Capex to operating income (%): 20.378829807446078
Buffett classification: The Great
Shares outstanding: 40174235
Book value: 272398294.7624848
Debt to equity: 0.16823094361895732
Current ratio: 1.2241701333622201
Quick ratio: 0.7741595629255477
Effective tax rate (%): 25.37446171129002
Interest coverage ratio: 6.927439198855509
COGS to revenue (%): 78.18498454183803
SG&A to revenue (%): 7.521826588038581
Free cash flow (dilution-adjusted): 54873325.213154696
Retained earnings: 191200974.4214373
Inventory turnover: 4.328046621422248
Receivables turnover: 4.458263890408903
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 48.536569719422324
FCF margin (%): 3.159735275469496
Revenue growth (%): 41.79662767675181
Rule of 40 score: 44.956362952221305
Financial ratios for APARINDS.NS — annual report dated 2024-03-31
Total revenue: 1924109605.4682815
Gross profit: 409143782.2280849
Operating income: 176645880.80105528
Net income: 98945916.77659191
Capital expenditures: 39527521.28552584
Operating cash flow: -33971699.24451373
Depreciation & amortization: 13875764.480153495
Net tangible assets: 464518527.40136707
Owner earnings: 73294159.97121957
Return on net tangible assets (%): 15.778522415724824
Capex to operating income (%): 22.3767014018533
Buffett classification: The Great
Shares outstanding: 40174235
Book value: 464855498.2611823
Debt to equity: 0.12269278691992377
Current ratio: 1.5368063654490047
Quick ratio: 0.9979891651931829
Effective tax rate (%): 25.386806528914413
Interest coverage ratio: 5.2019987993078365
COGS to revenue (%): 78.7359420136303
SG&A to revenue (%): 5.412725963920561
Free cash flow (dilution-adjusted): -73625134.90826239
Retained earnings: 268574169.564696
Inventory turnover: 4.410360067866195
Receivables turnover: 4.083868044826682
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 34.26048246797348
FCF margin (%): -3.8264522301131496
Revenue growth (%): 10.794761765418816
Rule of 40 score: 6.968309535305666
Financial ratios for APARINDS.NS — quarterly report dated 2024-09-30
Total revenue: 552245580.50645
Gross profit: 105446727.18585762
Operating income: 38757763.97515528
Net income: 23098423.31581462
Capital expenditures: 0
Depreciation & amortization: 3829431.43812709
Net tangible assets: 490172001.91113234
Owner earnings: 26927854.75394171
Return on net tangible assets (%): 5.493552191669997
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 40174235
Book value: 490618729.09698987
Debt to equity: 0.13217657627828394
Current ratio: 1.5115536757765495
Quick ratio: 0.952405484663549
Effective tax rate (%): 24.480972227632144
Interest coverage ratio: 3.2267303102625298
COGS to revenue (%): 80.90582688065061
Inventory turnover: 1.2050513836538772
Receivables turnover: 1.1469923515650389
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.096057454271895
Rule of 40 score: 0
Financial ratios for APARINDS.NS — quarterly report dated 2024-12-31
Total revenue: 547441426.7397132
Gross profit: 108722461.82538757
Operating income: 37618603.566849284
Net income: 20389322.76489101
Capital expenditures: 0
Depreciation & amortization: 3889730.737848234
Owner earnings: 24279053.502739243
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 40174235
Effective tax rate (%): 26.65324778798172
Interest coverage ratio: 2.726911702577102
COGS to revenue (%): 80.13989140849569
Capitalized R&D asset: 0
Revenue growth (%): -0.8699306859696551
Rule of 40 score: -0.8699306859696551
Financial ratios for APARINDS.NS — quarterly report dated 2025-03-31
Total revenue: 606584054.2436286
Gross profit: 128805237.3158756
Operating income: 49056581.71615618
Net income: 29224924.01215805
Capital expenditures: 0
Depreciation & amortization: 4164133.7386018233
Net tangible assets: 525955108.7210661
Owner earnings: 33389057.750759874
Return on net tangible assets (%): 6.3482714013274
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 40174235
Book value: 526483516.48351645
Debt to equity: 0.1298311994564276
Current ratio: 1.4702609596253828
Quick ratio: 0.9475996735044436
Effective tax rate (%): 26.484340538156154
Interest coverage ratio: 4.2110386352232805
COGS to revenue (%): 78.76547587844402
Retained earnings: 333693009.118541
Inventory turnover: 1.2345325479534814
Receivables turnover: 1.2723157690827014
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.512420835683074
Revenue growth (%): 10.803462181541372
Rule of 40 score: 10.803462181541372
Financial ratios for APARINDS.NS — annual report dated 2025-03-31
Total revenue: 2161850596.2122984
Gross profit: 438757306.52326393
Operating income: 167646714.9871405
Net income: 96013560.90717793
Capital expenditures: 59252981.0614917
Operating cash flow: 150962122.98339957
Depreciation & amortization: 15448912.78933832
Net tangible assets: 525955108.7210661
Owner earnings: 52209492.63502455
Return on net tangible assets (%): 9.926606238691981
Capex to operating income (%): 35.34395592901224
Buffett classification: The Good
Shares outstanding: 40174235
Book value: 526483516.48351645
Debt to equity: 0.1298311994564276
Current ratio: 1.4702609596253828
Quick ratio: 0.9475996735044436
Effective tax rate (%): 25.717231648637895
Interest coverage ratio: 3.5070064317331444
COGS to revenue (%): 79.70455001414088
SG&A to revenue (%): 5.121598142379033
Free cash flow (dilution-adjusted): 91096563.01145662
Retained earnings: 333693009.118541
Inventory turnover: 4.4523002567587975
Receivables turnover: 4.534501994767261
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.090477562165034
FCF margin (%): 4.213823248057182
Revenue growth (%): 12.355896465999736
Rule of 40 score: 16.569719714056916
Financial ratios for APARINDS.NS — quarterly report dated 2025-06-30
Total revenue: 594921600.7488884
Gross profit: 122976831.26608941
Operating income: 48448396.91083548
Net income: 30764100.16381933
Capital expenditures: 0
Depreciation & amortization: 4471097.589515563
Owner earnings: 35235197.753334895
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 40174235
Effective tax rate (%): 25.419834335640534
Interest coverage ratio: 4.796570898980538
COGS to revenue (%): 79.32890130207309
Capitalized R&D asset: 0
Revenue growth (%): -1.9226442589696129
Rule of 40 score: -1.9226442589696129
Financial ratios for APARINDS.NS — quarterly report dated 2025-12-31
Total revenue: 608336860.8666593
Gross profit: 118243288.40369834
Operating income: 44989417.40002228
Net income: 23273922.245739114
Capital expenditures: 0
Depreciation & amortization: 4518213.211540604
Owner earnings: 27792135.45727972
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 40174235
Effective tax rate (%): 27.475006942515968
Interest coverage ratio: 3.806503298774741
COGS to revenue (%): 80.56285982157245
Capitalized R&D asset: 0
Revenue growth (%): 2.254962687669057
Rule of 40 score: 2.254962687669057
Financial ratios for BALY — annual report dated 2021-12-31
Total revenue: 1322443000
Gross profit: 787364000
Operating income: 145920000
Net income: -114697000
Capital expenditures: 144000000
Operating cash flow: 82754000
Depreciation & amortization: 144786000
Owner earnings: -113911000
Capex to operating income (%): 98.68421052631578
Buffett classification: The Gruesome
Shares outstanding: 48948795
Interest coverage ratio: 1.2374071435840033
COGS to revenue (%): 40.46140362949481
SG&A to revenue (%): 41.175385252899375
Free cash flow (dilution-adjusted): -100121000
Capitalized R&D asset: 0
FCF margin (%): -7.570912319094282
Rule of 40 score: -7.570912319094282
Financial ratios for BALY — annual report dated 2022-12-31
Total revenue: 2255705000
Gross profit: 1246469000
Operating income: 169684000
Net income: -425546000
Capital expenditures: 150000000
Operating cash flow: 270971000
Depreciation & amortization: 300559000
Net tangible assets: -2902321000
Owner earnings: -274987000
Capex to operating income (%): 88.39961339902406
Buffett classification: The Gruesome
Shares outstanding: 48948795
Book value: 806247000
Debt to equity: 5.612046928546711
Current ratio: 0.6916004456193553
Quick ratio: 0.6728243640530192
Interest coverage ratio: 0.81278350712989
COGS to revenue (%): 44.74148880283548
SG&A to revenue (%): 34.41168060539832
Free cash flow (dilution-adjusted): -62100000
Retained earnings: -535373000
Inventory turnover: 71.11803255584526
Receivables turnover: 13.538914464404684
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0605065264196036
FCF margin (%): -2.753019565945015
Revenue growth (%): 70.57105674875969
Rule of 40 score: 67.81803718281468
Financial ratios for BALY — annual report dated 2023-12-31
Total revenue: 2449073000
Gross profit: 1343897000
Operating income: 104702000
Net income: -187500000
Capital expenditures: 411000000
Operating cash flow: 188614000
Depreciation & amortization: 350408000
Net tangible assets: -3171805000
Owner earnings: -248092000
Capex to operating income (%): 392.5426448396401
Buffett classification: The Gruesome
Shares outstanding: 48948795
Book value: 635854000
Debt to equity: 7.967055330311675
Current ratio: 0.6542730743729852
Quick ratio: 0.6375500125745902
Interest coverage ratio: 0.3691109074243813
COGS to revenue (%): 45.126298807752974
SG&A to revenue (%): 36.29075164358106
Free cash flow (dilution-adjusted): -337628000
Retained earnings: -555895000
Inventory turnover: 75.5469273361132
Receivables turnover: 14.826871617285596
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7490202249360751
FCF margin (%): -13.785950847524758
Revenue growth (%): 8.572397543118448
Rule of 40 score: -5.213553304406309
Financial ratios for BALY — quarterly report dated 2024-09-30
Total revenue: 629974000
Gross profit: 343738000
Operating income: 8398000
Net income: -247855000
Capital expenditures: 0
Operating cash flow: 36478000
Depreciation & amortization: 92470000
Owner earnings: -155385000
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 48948795
Interest coverage ratio: 0.11352483947279486
COGS to revenue (%): 45.43616085743221
SG&A to revenue (%): 40.88105223390171
Free cash flow (dilution-adjusted): -71987000
Capitalized R&D asset: 0
FCF margin (%): -11.426979526139174
Rule of 40 score: -11.426979526139174
Financial ratios for BATAINDIA.NS — annual report dated 2023-03-31
Total revenue: 420287332.5213155
Gross profit: 226302070.6455542
Operating income: 62326431.181485996
Net income: 39342752.74056029
Capital expenditures: 10923751.522533497
Operating cash flow: 76591473.81242388
Depreciation & amortization: 35905481.12058465
Net tangible assets: 173182825.8221681
Owner earnings: 64324482.33861145
Return on net tangible assets (%): 37.1425295973994
Capex to operating income (%): 17.52667578659371
Buffett classification: The Great
Shares outstanding: 128527540
Book value: 175177831.91230208
Debt to equity: 0.8666662031274988
Current ratio: 1.9618466424461727
Quick ratio: 0.8620088419393904
Effective tax rate (%): 24.8539555876092
Interest coverage ratio: 4.7444646367244
COGS to revenue (%): 46.15539105402921
SG&A to revenue (%): 8.941073026138662
Free cash flow (dilution-adjusted): 64970280.14616322
Retained earnings: 142987332.5213155
Inventory turnover: 1.7606657417183034
Receivables turnover: 41.79759914722485
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.89239985366746
FCF margin (%): 15.458538746910284
Rule of 40 score: 15.458538746910284
Financial ratios for BATAINDIA.NS — annual report dated 2024-03-31
Total revenue: 416969300.8754047
Gross profit: 228155054.56289724
Operating income: 55220889.79493944
Net income: 31479913.658712074
Capital expenditures: 11739057.44094016
Operating cash flow: 54336251.34908263
Depreciation & amortization: 40662069.79254107
Net tangible assets: 179619019.06703442
Owner earnings: 60402926.01031299
Return on net tangible assets (%): 33.62835757819745
Capex to operating income (%): 21.258363428283534
Buffett classification: The Great
Shares outstanding: 128527540
Book value: 183102650.19786543
Debt to equity: 0.8889254191354601
Current ratio: 2.1088274016124995
Quick ratio: 0.8445738627090428
Effective tax rate (%): 25.132047274635518
Interest coverage ratio: 3.935618135977095
COGS to revenue (%): 45.28252941310117
SG&A to revenue (%): 10.025547099931064
Free cash flow (dilution-adjusted): 42235999.520326175
Retained earnings: 151410121.11764002
Inventory turnover: 1.6938540153837878
Receivables turnover: 43.39224030349922
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.61277273794744
FCF margin (%): 10.129282762940571
Revenue growth (%): -0.7894674402880131
Rule of 40 score: 9.339815322652559
Financial ratios for BATAINDIA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 172449952.22169134
Buffett classification: The Gruesome
Shares outstanding: 128527540
Book value: 175499522.21691352
Debt to equity: 0.9786106411158647
Current ratio: 1.8091486795199236
Quick ratio: 0.8499558604516386
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BATAINDIA.NS — quarterly report dated 2024-12-31
Total revenue: 107098030.07343513
Gross profit: 60872595.87364494
Operating income: 12682946.730388157
Net income: 6842172.747406458
Capital expenditures: 0
Depreciation & amortization: 10511598.088355286
Owner earnings: 17353770.835761745
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 128527540
Effective tax rate (%): 24.06830088610051
Interest coverage ratio: 3.497043131709199
COGS to revenue (%): 43.161796877210776
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BATAINDIA.NS — quarterly report dated 2025-03-31
Total revenue: 92145662.8477905
Gross profit: 54174187.51461304
Operating income: 8667173.252279636
Net income: 5367664.250642974
Capital expenditures: 0
Depreciation & amortization: 12123100.303951368
Net tangible assets: 152850830.02104276
Owner earnings: 17490764.55459434
Return on net tangible assets (%): 11.443028835490402
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 128527540
Book value: 184120060.79027358
Debt to equity: 0.9184031624869916
Current ratio: 1.835519476988719
Quick ratio: 0.9669557003389295
Effective tax rate (%): 26.15674102188842
Interest coverage ratio: 2.1329439857303147
COGS to revenue (%): 41.208098308327436
Retained earnings: 153224105.68155247
Inventory turnover: 0.398697880864937
Receivables turnover: 7.052548696795898
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5699064540046743
Revenue growth (%): -13.961383991276099
Rule of 40 score: -13.961383991276099
Financial ratios for BATAINDIA.NS — annual report dated 2025-03-31
Total revenue: 407703179.79892445
Gross profit: 220803016.13280335
Operating income: 45228898.76081365
Net income: 38655132.10194061
Capital expenditures: 7983399.579144259
Operating cash flow: 86254500.8183306
Depreciation & amortization: 43406710.31096563
Net tangible assets: 152850830.02104276
Owner earnings: 74078442.83376198
Return on net tangible assets (%): 48.46453422828237
Capex to operating income (%): 17.65110316163851
Buffett classification: The Great
Shares outstanding: 128527540
Book value: 184120060.79027358
Debt to equity: 0.9184031624869916
Current ratio: 1.835519476988719
Quick ratio: 0.9669557003389295
Effective tax rate (%): 22.44985071896467
Interest coverage ratio: 3.011387429460985
COGS to revenue (%): 45.84221387684506
SG&A to revenue (%): 9.154685041661732
Free cash flow (dilution-adjusted): 77767477.2036474
Retained earnings: 153224105.68155247
Inventory turnover: 1.9624388711039535
Receivables turnover: 31.204361013931265
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.41083597265893
FCF margin (%): 19.074532909456735
Revenue growth (%): -2.2222549854453417
Rule of 40 score: 16.852277924011393
Financial ratios for BATAINDIA.NS — quarterly report dated 2025-06-30
Total revenue: 110209922.77088697
Gross profit: 58946407.67610578
Operating income: 10850573.367657384
Net income: 6084600.9829159845
Capital expenditures: 0
Depreciation & amortization: 12413994.851392465
Owner earnings: 18498595.83430845
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 128527540
Effective tax rate (%): 25.7888652613852
Interest coverage ratio: 2.65950612326842
COGS to revenue (%): 46.51442792619663
Capitalized R&D asset: 0
Revenue growth (%): 19.60402623934202
Rule of 40 score: 19.60402623934202
Financial ratios for BATAINDIA.NS — quarterly report dated 2025-12-31
Total revenue: 105233485.5742453
Gross profit: 58934276.48434889
Operating income: 12035646.652556533
Net income: 7363484.460287401
Capital expenditures: 0
Depreciation & amortization: 11585162.080873344
Owner earnings: 18948646.541160747
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 128527540
Effective tax rate (%): 25.62111801242236
Interest coverage ratio: 3.346155037319211
COGS to revenue (%): 43.996650721248756
Capitalized R&D asset: 0
Revenue growth (%): -4.515416644458663
Rule of 40 score: -4.515416644458663
Financial ratios for BBK.DE — annual report dated 2022-12-31
Total revenue: 19973000000
Net income: 6267000000
Capital expenditures: 564000000
Operating cash flow: 11081000000
Depreciation & amortization: 1366000000
Net tangible assets: 26071000000
Owner earnings: 7069000000
Return on net tangible assets (%): 27.114418319205246
Buffett classification: The Gruesome
Shares outstanding: 1221626000
Book value: 60537000000
Debt to equity: 1.039793845086476
Effective tax rate (%): 17.783468487693842
COGS to revenue (%): 0
SG&A to revenue (%): 34.44149601962649
Free cash flow (dilution-adjusted): 11081000000
Retained earnings: 26264000000
Receivables turnover: 1.696653075093442
Capitalized R&D asset: 0
FCF margin (%): 55.47989786211386
Rule of 40 score: 55.47989786211386
Financial ratios for BBK.DE — annual report dated 2023-12-31
Total revenue: 20022000000
Net income: -1047000000
Capital expenditures: 0
Operating cash flow: 8631000000
Depreciation & amortization: 1215000000
Net tangible assets: 36658000000
Owner earnings: 168000000
Buffett classification: The Gruesome
Shares outstanding: 1221626000
Book value: 59253000000
Debt to equity: 1.007442661131082
COGS to revenue (%): 0
SG&A to revenue (%): 35.08640495454999
Free cash flow (dilution-adjusted): 8631000000
Retained earnings: 22088000000
Receivables turnover: 1.823497267759563
Capitalized R&D asset: 0
FCF margin (%): 43.10758166017381
Revenue growth (%): 0.24533119711610674
Rule of 40 score: 43.352912857289915
Financial ratios for BBK.DE — annual report dated 2024-12-31
Total revenue: 13278000000
Net income: 4840000000
Capital expenditures: 0
Operating cash flow: 2164000000
Depreciation & amortization: 979000000
Net tangible assets: 41296000000
Owner earnings: 5819000000
Return on net tangible assets (%): 14.090953118946144
Buffett classification: The Gruesome
Shares outstanding: 1221626000
Book value: 63679000000
Debt to equity: 0.8258609588718416
COGS to revenue (%): 0
SG&A to revenue (%): 51.62675101671938
Free cash flow (dilution-adjusted): 2164000000
Retained earnings: 23777000000
Receivables turnover: 1.0001506477854776
Capitalized R&D asset: 0
FCF margin (%): 16.297635186021992
Revenue growth (%): -33.682948756368
Rule of 40 score: -17.385313570346007
Financial ratios for BBK.DE — quarterly report dated 2025-03-31
Total revenue: 4899000000
Net income: 1261000000
Capital expenditures: 0
Operating cash flow: 746000000
Depreciation & amortization: 220000000
Net tangible assets: 42409000000
Owner earnings: 1481000000
Return on net tangible assets (%): 3.4921832629866305
Buffett classification: The Gruesome
Shares outstanding: 1221626000
Book value: 64635000000
Debt to equity: 0.8626904927670767
Effective tax rate (%): 17.850162866449512
COGS to revenue (%): 0
SG&A to revenue (%): 34.27230046948357
Free cash flow (dilution-adjusted): 746000000
Retained earnings: 24252000000
Receivables turnover: 0.3552831967510334
Capitalized R&D asset: 0
FCF margin (%): 15.227597468871199
Rule of 40 score: 15.227597468871199
Financial ratios for BBK.DE — quarterly report dated 2025-06-30
Total revenue: 4987000000
Net income: 1240000000
Capital expenditures: 0
Operating cash flow: 914000000
Depreciation & amortization: 212000000
Net tangible assets: 42704000000
Owner earnings: 1452000000
Return on net tangible assets (%): 3.4001498688647436
Buffett classification: The Gruesome
Shares outstanding: 1221626000
Book value: 64840000000
Debt to equity: 0.9416718075262184
Effective tax rate (%): 18.043621943159284
COGS to revenue (%): 0
SG&A to revenue (%): 34.79045518347704
Free cash flow (dilution-adjusted): 914000000
Retained earnings: 24759000000
Receivables turnover: 0.36300771582471975
Capitalized R&D asset: 0
FCF margin (%): 18.32765189492681
Revenue growth (%): 1.7962849561134926
Rule of 40 score: 20.123936851040302
Financial ratios for BBK.DE — quarterly report dated 2025-09-30
Total revenue: 5187000000
Net income: 1452000000
Capital expenditures: 0
Operating cash flow: 1497000000
Depreciation & amortization: 202000000
Net tangible assets: 43417000000
Owner earnings: 1654000000
Return on net tangible assets (%): 3.809567680862335
Buffett classification: The Gruesome
Shares outstanding: 1221626000
Book value: 65646000000
Debt to equity: 1.083158151296347
Effective tax rate (%): 16.407599309153714
COGS to revenue (%): 0
SG&A to revenue (%): 34.798534798534796
Free cash flow (dilution-adjusted): 1497000000
Retained earnings: 25438000000
Receivables turnover: 0.3725222637173226
Capitalized R&D asset: 0
FCF margin (%): 28.860613071139383
Revenue growth (%): 4.010427110487267
Rule of 40 score: 32.871040181626654
Financial ratios for BBK.DE — quarterly report dated 2025-12-31
Total revenue: 5246000000
Net income: 1354000000
Capital expenditures: 0
Operating cash flow: 2582000000
Depreciation & amortization: 203000000
Net tangible assets: 42836000000
Owner earnings: 1557000000
Return on net tangible assets (%): 3.634793164627883
Buffett classification: The Gruesome
Shares outstanding: 1221626000
Book value: 65189000000
Debt to equity: 0.9864394299651782
Effective tax rate (%): 13.427109974424553
COGS to revenue (%): 0
SG&A to revenue (%): 37.07586732748761
Free cash flow (dilution-adjusted): 2582000000
Retained earnings: 26067000000
Receivables turnover: 0.38761637357765627
Capitalized R&D asset: 0
FCF margin (%): 49.21845215402211
Revenue growth (%): 1.1374590321958744
Rule of 40 score: 50.35591118621799
Financial ratios for BBK.DE — annual report dated 2025-12-31
Total revenue: 20319000000
Net income: 5307000000
Capital expenditures: 0
Operating cash flow: 5739000000
Depreciation & amortization: 837000000
Net tangible assets: 42836000000
Owner earnings: 6144000000
Return on net tangible assets (%): 14.34307591745261
Buffett classification: The Gruesome
Shares outstanding: 1221626000
Book value: 65189000000
Debt to equity: 0.9864394299651782
Effective tax rate (%): 16.41203339108521
COGS to revenue (%): 0
SG&A to revenue (%): 35.173975097199666
Free cash flow (dilution-adjusted): 5739000000
Retained earnings: 26067000000
Receivables turnover: 1.5013299837446432
Capitalized R&D asset: 0
FCF margin (%): 28.244500221467593
Revenue growth (%): 53.027564392227745
Rule of 40 score: 81.27206461369533
Financial ratios for CAPILLARY.NS — annual report dated 2023-03-31
Total revenue: 31104993.90986602
Gross profit: 6198903.77588307
Operating income: -12434957.36906212
Net income: -10684409.257003656
Capital expenditures: 3434835.5663824608
Operating cash flow: -2443118.1485992693
Depreciation & amortization: 4819488.428745433
Net tangible assets: -4702436.053593179
Owner earnings: -9299756.394640684
Buffett classification: The Gruesome
Shares outstanding: 79471983
Book value: 22724604.14129111
Debt to equity: 0.8011781164073345
Current ratio: 0.6686839744533855
Quick ratio: 0.6686839744533855
Interest coverage ratio: -9.91367255777821
COGS to revenue (%): 80.07103362937204
SG&A to revenue (%): 17.251695565684567
Free cash flow (dilution-adjusted): -13193544.457978077
Retained earnings: -55623629.71985384
Receivables turnover: 3.187727028747613
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -42.12509077705156
FCF margin (%): -42.41616152123177
Rule of 40 score: -42.41616152123177
Financial ratios for CAPILLARY.NS — annual report dated 2024-03-31
Total revenue: 62969180.95694927
Gross profit: 16895670.943758246
Operating income: -7479194.147979374
Net income: -7120518.047727545
Capital expenditures: 4401127.233481233
Operating cash flow: 11648279.170164289
Depreciation & amortization: 6981652.476316105
Net tangible assets: 28877563.25698525
Owner earnings: -4539992.804892673
Return on net tangible assets (%): -15.721523192558449
Buffett classification: The Gruesome
Shares outstanding: 79471983
Book value: 64630291.40184674
Debt to equity: 0.14900955929284984
Current ratio: 1.5045102738507614
Quick ratio: 1.5045102738507614
Interest coverage ratio: -3.7036223277909737
COGS to revenue (%): 73.16834888592649
SG&A to revenue (%): 18.997714721005522
Free cash flow (dilution-adjusted): 6393932.126154215
Retained earnings: -61932365.99112603
Receivables turnover: 3.605193235885782
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.099958176495193
FCF margin (%): 10.154065892211008
Revenue growth (%): 102.44074356489885
Rule of 40 score: 112.59480945710986
Financial ratios for CAPILLARY.NS — quarterly report dated 2024-12-31
Total revenue: 18533628.628045224
Gross profit: 7000699.382212379
Operating income: 1179624.6648793565
Net income: 1195943.5831682014
Capital expenditures: 0
Depreciation & amortization: 1496911.0618953258
Owner earnings: 2692854.645063527
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 79471983
Effective tax rate (%): -14.81295253419147
Interest coverage ratio: 6.0562537402752845
COGS to revenue (%): 62.22704402515724
SG&A to revenue (%): 15.822641509433963
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAPILLARY.NS — quarterly report dated 2025-03-31
Total revenue: 17779050.736497544
Gross profit: 7349660.977320551
Operating income: 1290390.4606032264
Net income: 1150572.8314238952
Capital expenditures: 0
Depreciation & amortization: 1928571.4285714284
Net tangible assets: 32348608.837970536
Owner earnings: 3079144.2599953236
Return on net tangible assets (%): 9.518629612229411
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 79471983
Book value: 66430558.80289923
Debt to equity: 0.18728827428917352
Current ratio: 1.6682436097903435
Quick ratio: 1.6682436097903435
Effective tax rate (%): -8.92050209205021
Interest coverage ratio: 6.911709455228553
COGS to revenue (%): 58.66111702897121
SG&A to revenue (%): 17.62930524322405
Retained earnings: -54860883.79705401
Receivables turnover: 0.9438993054909044
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8773449804237716
Revenue growth (%): -4.071398573325501
Rule of 40 score: -4.071398573325501
Financial ratios for CAPILLARY.NS — annual report dated 2025-03-31
Total revenue: 69939092.82207154
Gross profit: 24614683.189151272
Operating income: 568155.2490063128
Net income: 1552490.0631283608
Capital expenditures: 5540799.625906008
Operating cash flow: -5400865.092354454
Depreciation & amortization: 7271218.143558568
Net tangible assets: 32348608.837970536
Owner earnings: 3282908.5807809206
Return on net tangible assets (%): 10.148530952983267
Capex to operating income (%): 975.2263374485595
Buffett classification: The Gruesome
Shares outstanding: 79471983
Book value: 66430558.80289923
Debt to equity: 0.18728827428917352
Current ratio: 1.6682436097903435
Quick ratio: 1.6682436097903435
Effective tax rate (%): -32.50327653997378
Interest coverage ratio: 0.6240369799691834
COGS to revenue (%): 64.80554408709271
SG&A to revenue (%): 16.63042260960554
Free cash flow (dilution-adjusted): -11895136.7781155
Retained earnings: -54860883.79705401
Receivables turnover: 3.7131038163864423
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8265896543630669
FCF margin (%): -17.00785111465101
Revenue growth (%): 11.068766909779962
Rule of 40 score: -5.939084204871049
Financial ratios for CAPILLARY.NS — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 17607891.770011272
Buffett classification: The Gruesome
Shares outstanding: 79471983
Book value: 67215107.10259302
Debt to equity: 0.1679978798989597
Current ratio: 1.175553108272751
Quick ratio: 1.175553108272751
Retained earnings: -52805524.23900789
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DIGIDRIVE.NS — annual report dated 2023-03-31
Total revenue: 5228989.037758831
Gross profit: 1801827.0401948844
Operating income: -104531.05968331304
Net income: 566138.8550548112
Capital expenditures: 3824.6041412911086
Operating cash flow: -1044616.3215590743
Depreciation & amortization: 51132.76492082826
Net tangible assets: 16513215.590742998
Owner earnings: 613447.0158343484
Return on net tangible assets (%): 3.714885283628438
Buffett classification: The Gruesome
Shares outstanding: 38469018
Book value: 16513215.590742998
Debt to equity: 0.003232932689648051
Current ratio: 8.543430878622218
Quick ratio: 6.9565155250652095
Effective tax rate (%): 26.581158779301195
Interest coverage ratio: -14.04582651391162
COGS to revenue (%): 65.54157931516423
SG&A to revenue (%): 4.068017703237829
Free cash flow (dilution-adjusted): -1048440.9257003654
Retained earnings: 848465.2862362972
Inventory turnover: 6.33530722986513
Receivables turnover: 13.377165648759815
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5972043709625902
FCF margin (%): -20.050547402748663
Rule of 40 score: -20.050547402748663
Financial ratios for PLRZ — annual report dated 2022-12-31
Total revenue: 0
Operating income: -254261.36363636365
Net income: -221306.81818181818
Capital expenditures: 852.2727272727273
Operating cash flow: -321590.9090909091
Depreciation & amortization: 1420.4545454545455
Net tangible assets: -255681.81818181818
Owner earnings: -220738.63636363635
Buffett classification: The Gruesome
Shares outstanding: 2083979
Book value: -255681.81818181818
Debt to equity: -0.6911111111111111
Current ratio: 0.042570951585976624
Quick ratio: 0.042570951585976624
Free cash flow (dilution-adjusted): -359375
Retained earnings: -829829.5454545454
Capitalized R&D asset: 98579.54545454546
Rule of 40 score: 0
Financial ratios for PLRZ — annual report dated 2023-12-31
Total revenue: 0
Operating income: -175414.36464088398
Net income: -165745.85635359117
Capital expenditures: 0
Operating cash flow: -148342.5414364641
Depreciation & amortization: 1104.9723756906078
Net tangible assets: -52762.43093922652
Owner earnings: -164640.88397790055
Buffett classification: The Gruesome
Shares outstanding: 2083979
Book value: -52762.4309392265
Debt to equity: -1.047120418848168
Current ratio: 0.10756972111553785
Quick ratio: 0.10756972111553785
Free cash flow (dilution-adjusted): -175966.85082872928
Retained earnings: -972651.9337016575
Capitalized R&D asset: 157761.0026368659
ROCI (R&D-adjusted, %): -84.79918845491358
Rule of 40 score: 0
Financial ratios for SHIM — annual report dated 2022-12-31
Total revenue: 664158000
Gross profit: 23515000
Operating income: -39559000
Net income: 3760000
Capital expenditures: 10443000
Operating cash flow: -3084000
Depreciation & amortization: 15979000
Net tangible assets: 40599000
Owner earnings: 9296000
Return on net tangible assets (%): 22.89711569250474
Buffett classification: The Gruesome
Shares outstanding: 40986160
Book value: 51595000
Debt to equity: 0.27991084407403816
Current ratio: 0.6847928105495331
Quick ratio: 0.6847928105495331
Effective tax rate (%): 30.471179143745513
COGS to revenue (%): 96.45942682313546
SG&A to revenue (%): 9.100545352160179
Free cash flow (dilution-adjusted): -15822000
Retained earnings: 49083000
Receivables turnover: 4.836184109924198
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -37.37093193519437
FCF margin (%): -2.382264461167373
Rule of 40 score: -2.382264461167373
Financial ratios for VENU — annual report dated 2022-12-31
Total revenue: 8656867
Gross profit: 3300232
Operating income: -4553710
Net income: -6923749
Capital expenditures: 8119210
Operating cash flow: -700748
Depreciation & amortization: 1176552
Net tangible assets: 15622408
Owner earnings: -13866407
Return on net tangible assets (%): -88.75972897392003
Buffett classification: The Gruesome
Shares outstanding: 57481545
Book value: 38760137
Debt to equity: 0.29472026891958614
Current ratio: 6.832892093806865
Quick ratio: 6.807928620305153
Interest coverage ratio: -11.466836220789686
COGS to revenue (%): 61.87729348273457
SG&A to revenue (%): 7.810851200555582
Free cash flow (dilution-adjusted): -9793637
Retained earnings: -6496980
Inventory turnover: 61.46101772703803
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.216737511608182
FCF margin (%): -113.13142502940153
Rule of 40 score: -113.13142502940153
Financial ratios for VENU — annual report dated 2023-12-31
Total revenue: 12597664
Gross profit: 4826068
Operating income: -11132168
Net income: -10524473
Capital expenditures: 31165063
Operating cash flow: -4876172
Depreciation & amortization: 1877236
Net tangible assets: 30475827
Owner earnings: -39812300
Return on net tangible assets (%): -130.63566740945208
Buffett classification: The Gruesome
Shares outstanding: 57481545
Book value: 61979685
Debt to equity: 0.24822092916412852
Current ratio: 4.189969859002955
Quick ratio: 4.152182536937776
Interest coverage ratio: -33.56358351875637
COGS to revenue (%): 61.69077060636003
SG&A to revenue (%): 111.7746909268258
Free cash flow (dilution-adjusted): -37651585
Retained earnings: -17021453
Inventory turnover: 41.83991041529831
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.215849812707217
FCF margin (%): -298.87751411690294
Revenue growth (%): 45.52220797662711
Rule of 40 score: -253.35530614027584
Financial ratios for 1776.T — annual report dated 2022-03-31
Total revenue: 258441239.14112443
Gross profit: 26323553.51581708
Operating income: 7646287.493853467
Net income: 5138501.884936896
Capital expenditures: 7490575.315522046
Operating cash flow: 1598098.6723487952
Depreciation & amortization: 4499262.415997378
Net tangible assets: 105638419.93115883
Owner earnings: 2147188.985412228
Return on net tangible assets (%): 2.032583397982933
Capex to operating income (%): 97.96355841371918
Buffett classification: The Gruesome
Shares outstanding: 9204847
Book value: 106302245.5335191
Debt to equity: 0.0005396654074473826
Current ratio: 1.746389270976616
Quick ratio: 1.7248968363136172
Effective tax rate (%): 31.99566160520607
COGS to revenue (%): 89.81449183446962
Free cash flow (dilution-adjusted): -6007211.932470087
Retained earnings: 82060317.9806589
Inventory turnover: 113.292
Receivables turnover: 3.057791137399399
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.194807781687802
FCF margin (%): -2.324401458696686
Rule of 40 score: -2.324401458696686
Financial ratios for 1776.T — annual report dated 2023-03-31
Total revenue: 239594594.59459463
Gross profit: 24384384.384384386
Operating income: 7575075.075075076
Net income: 4729729.72972973
Capital expenditures: 5938438.438438439
Operating cash flow: 16073573.573573574
Depreciation & amortization: 3528528.5285285288
Net tangible assets: 99729729.72972974
Owner earnings: 2319819.81981982
Return on net tangible assets (%): 2.3261065943992776
Capex to operating income (%): 78.39444995044597
Buffett classification: The Gruesome
Shares outstanding: 9204847
Book value: 100270270.27027027
Debt to equity: 0.0018718179095537587
Current ratio: 1.6720188902007083
Quick ratio: 1.6485635576544666
Effective tax rate (%): 33.71848739495798
COGS to revenue (%): 89.8195149464185
Free cash flow (dilution-adjusted): 10105105.105105106
Retained earnings: 77822822.82282282
Inventory turnover: 96.19127516778524
Receivables turnover: 3.2732307692307696
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.526942234297175
FCF margin (%): 4.217584759039919
Revenue growth (%): -7.292429261352675
Rule of 40 score: -3.0748445023127555
Financial ratios for 1776.T — annual report dated 2024-03-31
Total revenue: 204127047.01531962
Gross profit: 20958795.562599048
Operating income: 6563655.57316429
Net income: 3876122.556788167
Capital expenditures: 6398573.692551506
Operating cash flow: 11998151.082937136
Depreciation & amortization: 3618594.823032224
Net tangible assets: 89659270.99841522
Owner earnings: 1096143.6872688858
Return on net tangible assets (%): 1.2225659154514659
Capex to operating income (%): 97.48490945674044
Buffett classification: The Gruesome
Shares outstanding: 9204847
Book value: 90141310.08980455
Debt to equity: 0.0024174053182917004
Current ratio: 1.7110278818143985
Quick ratio: 1.6836454431960048
Effective tax rate (%): 34.66666666666667
COGS to revenue (%): 89.73247501051337
Free cash flow (dilution-adjusted): 5487321.711568939
Retained earnings: 70192815.63655573
Inventory turnover: 84.3130699088146
Receivables turnover: 3.4815857641626313
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.339690031251995
FCF margin (%): 2.6881894348655906
Revenue growth (%): -14.803150145890301
Rule of 40 score: -12.114960711024711
Financial ratios for 1776.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 90341784.56366438
Buffett classification: The Gruesome
Shares outstanding: 9204847
Book value: 91791567.44642109
Debt to equity: 0
Current ratio: 2.086670323642348
Quick ratio: 2.0178277564454197
Retained earnings: 70535088.94803193
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1776.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 89994653.12124047
Buffett classification: The Gruesome
Shares outstanding: 9204847
Book value: 90622911.37548456
Debt to equity: 0.0025075595545394204
Current ratio: 1.910058133157837
Quick ratio: 1.8750685532521663
Retained earnings: 69696564.630397
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 1776.T — annual report dated 2025-03-31
Total revenue: 201557278.4387114
Gross profit: 16428284.988637881
Operating income: 1503809.651116161
Net income: 1116160.9410506617
Capital expenditures: 2680122.978211469
Operating cash flow: -21026600.721828632
Depreciation & amortization: 3923272.289800829
Net tangible assets: 89994653.12124047
Owner earnings: 2359310.252640021
Return on net tangible assets (%): 2.621611585592276
Capex to operating income (%): 178.22222222222223
Buffett classification: The Gruesome
Shares outstanding: 9204847
Book value: 90622911.37548456
Debt to equity: 0.0025075595545394204
Current ratio: 1.910058133157837
Quick ratio: 1.8750685532521663
Effective tax rate (%): 28.510638297872337
COGS to revenue (%): 91.84600590244388
Free cash flow (dilution-adjusted): -24034220.024060953
Retained earnings: 69696564.630397
Inventory turnover: 86.82758620689654
Receivables turnover: 3.197985153764581
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4574426739214927
FCF margin (%): -11.924263023510296
Revenue growth (%): -1.2589064576118378
Rule of 40 score: -13.183169481122134
Financial ratios for 227A.T — annual report dated 2022-12-31
Total revenue: 9733862.473668372
Gross profit: 3813474.2702377373
Operating income: 990979.5365633465
Net income: 895109.8405055674
Capital expenditures: 22833.283177851343
Operating cash flow: 309298.8263617214
Depreciation & amortization: 54980.439362022276
Net tangible assets: 841039.7231417395
Owner earnings: 927256.9966897384
Return on net tangible assets (%): 110.25127246379405
Capex to operating income (%): 2.3041124801664123
Buffett classification: The Great
Shares outstanding: 800000
Book value: 841039.7231417391
Debt to equity: 1.58336538719575
Current ratio: 1.559067462504044
Quick ratio: 1.559067462504044
Effective tax rate (%): 29.057724299539085
Interest coverage ratio: 70.93214862681745
COGS to revenue (%): 60.822522365853196
Free cash flow (dilution-adjusted): 286465.54318387003
Retained earnings: 761758.952753536
Receivables turnover: 5.8276730296287615
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 66.06861614084366
FCF margin (%): 2.942979150967094
Rule of 40 score: 2.942979150967094
Financial ratios for 227A.T — annual report dated 2023-12-31
Total revenue: 8582959.76808315
Gross profit: 3267772.042706639
Operating income: -159612.52916637206
Net income: -100028.28254260057
Capital expenditures: 268337.6935586509
Operating cash flow: -287138.5137523863
Depreciation & amortization: 39850.10252421693
Net tangible assets: 690405.1474227533
Owner earnings: -328515.87357703457
Return on net tangible assets (%): -47.583056818647336
Buffett classification: The Gruesome
Shares outstanding: 800000
Book value: 690405.1474227533
Debt to equity: 2.4018270451845476
Current ratio: 1.7331103164532626
Quick ratio: 1.7331103164532626
Interest coverage ratio: -12.703432751828926
COGS to revenue (%): 61.92721239521274
Free cash flow (dilution-adjusted): -555476.2073110372
Retained earnings: 615894.7889415259
Receivables turnover: 5.73245748664743
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.335671979085122
FCF margin (%): -6.47184913270417
Revenue growth (%): -11.82370008512649
Rule of 40 score: -18.29554921783066
Financial ratios for 285A.T — annual report dated 2024-03-31
Total revenue: 7108980454.305336
Gross profit: -854087427.3639725
Operating income: -1668634442.683571
Net income: -1609356840.9931326
Capital expenditures: 1935353935.552034
Operating cash flow: 1288371632.3296356
Depreciation & amortization: 2285169043.8457475
Net tangible assets: 7613701796.090861
Owner earnings: -1259541732.699419
Return on net tangible assets (%): -16.54309252492804
Buffett classification: The Gruesome
Shares outstanding: 547242487
Book value: 7613701796.09086
Debt to equity: 0.6074661388927677
Current ratio: 1.006645632411012
Quick ratio: 1.006645632411012
Interest coverage ratio: -2.724800517576019
COGS to revenue (%): 112.01420418657531
SG&A to revenue (%): 11.961351831348042
Free cash flow (dilution-adjusted): -726267828.8431062
Retained earnings: 16204437.400950871
Receivables turnover: 141.22838777384231
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.87041567966295
FCF margin (%): -10.216202358571183
Rule of 40 score: -10.216202358571183
Financial ratios for 520A.T — annual report dated 2024-03-31
Total revenue: 0
Operating income: -10793713.681986265
Net income: -10910835.974643424
Capital expenditures: 14679.080824088749
Operating cash flow: -9319228.737453777
Depreciation & amortization: 14943.211833069203
Net tangible assets: 6273923.666138405
Owner earnings: -10910571.843634443
Return on net tangible assets (%): -173.90348407521975
Buffett classification: The Gruesome
Shares outstanding: 17984645
Book value: 6273923.666138405
Debt to equity: 0
Current ratio: 5.957652113388383
Quick ratio: 5.957652113388383
Free cash flow (dilution-adjusted): -11187949.022715267
Retained earnings: -10910835.974643424
Capitalized R&D asset: 7370978.605388273
ROCI (R&D-adjusted, %): -41.923095212648505
Rule of 40 score: 0
Financial ratios for 520A.T — annual report dated 2025-03-31
Total revenue: 0
Operating income: -10046778.505547386
Net income: -10018760.86084748
Capital expenditures: 1276.5673038363855
Operating cash flow: -11327790.402352626
Depreciation & amortization: 1276.5673038363855
Net tangible assets: 15892721.561288597
Owner earnings: -10018760.86084748
Return on net tangible assets (%): -63.0399319727033
Buffett classification: The Gruesome
Shares outstanding: 17984645
Book value: 15892721.561288599
Debt to equity: 0
Current ratio: 6.2820810118291615
Quick ratio: 6.2820810118291615
Free cash flow (dilution-adjusted): -11541765.80671033
Retained earnings: -10018767.54444593
Capitalized R&D asset: 13072521.71293002
ROCI (R&D-adjusted, %): -24.296083611108635
Rule of 40 score: 0
Financial ratios for 7925.T — annual report dated 2022-03-31
Total revenue: 179306671.03753483
Gross profit: 60055728.569087036
Operating income: 10998197.01688248
Net income: 6531716.112112769
Capital expenditures: 5269627.929847566
Operating cash flow: 14366497.295525324
Depreciation & amortization: 8924766.431732504
Net tangible assets: 304032125.88100314
Owner earnings: 10186854.613997707
Return on net tangible assets (%): 3.3505849371933802
Capex to operating income (%): 47.91356184798808
Buffett classification: The Good
Shares outstanding: 14852991
Book value: 307490575.3155221
Debt to equity: 0.011460554371002131
Current ratio: 3.930493596200892
Quick ratio: 3.4633760253273853
Effective tax rate (%): 41.867250182348656
Interest coverage ratio: 268.4
COGS to revenue (%): 66.50212532565473
Free cash flow (dilution-adjusted): 6769382.068513359
Retained earnings: 222996230.1262088
Inventory turnover: 4.482439926062846
Receivables turnover: 3.8723893805309735
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.5019962944599565
FCF margin (%): 3.775309657662599
Rule of 40 score: 3.775309657662599
Financial ratios for 7925.T — annual report dated 2023-03-31
Total revenue: 176388888.8888889
Gross profit: 62379879.879879884
Operating income: 14617117.117117118
Net income: 11021021.021021022
Capital expenditures: 5510510.510510511
Operating cash flow: 13393393.393393394
Depreciation & amortization: 8490990.990990993
Net tangible assets: 283618618.61861867
Owner earnings: 14001501.5015015
Return on net tangible assets (%): 4.936735666260786
Capex to operating income (%): 37.699024139702104
Buffett classification: The Good
Shares outstanding: 14852991
Book value: 287942942.942943
Debt to equity: 0.010168430932888354
Current ratio: 3.9607293127629735
Quick ratio: 3.411360448807854
Effective tax rate (%): 32.45977011494253
Interest coverage ratio: 324.5
COGS to revenue (%): 64.63077250478825
Free cash flow (dilution-adjusted): 7702702.702702703
Retained earnings: 209647147.14714718
Inventory turnover: 3.8766913454174112
Receivables turnover: 4.336471022517533
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.944636326696465
FCF margin (%): 4.366886571610981
Revenue growth (%): -1.6272579998070171
Rule of 40 score: 2.739628571803964
Financial ratios for 7925.T — annual report dated 2024-03-31
Total revenue: 157983359.74643424
Gross profit: 54655309.03328051
Operating income: 11707606.973058637
Net income: 9033280.507131537
Capital expenditures: 4027997.886951928
Operating cash flow: 17267564.7120972
Depreciation & amortization: 6834389.857369255
Net tangible assets: 262618858.9540412
Owner earnings: 11839672.477548864
Return on net tangible assets (%): 4.5083100751804075
Capex to operating income (%): 34.40496333897349
Buffett classification: The Good
Shares outstanding: 14852991
Book value: 266897781.29952455
Debt to equity: 0.008164477102352855
Current ratio: 3.97884667205605
Quick ratio: 3.444489355968742
Effective tax rate (%): 34.576757532281206
Interest coverage ratio: 354.6
COGS to revenue (%): 65.40438871473353
Free cash flow (dilution-adjusted): 12334918.119387217
Retained earnings: 188464078.18277866
Inventory turnover: 3.9455370650529495
Receivables turnover: 4.803252358964064
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.228375187808544
FCF margin (%): 7.80773249738767
Revenue growth (%): -10.43463069493492
Rule of 40 score: -2.6268981975472503
Financial ratios for 7925.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 281713125.0875473
Buffett classification: The Gruesome
Shares outstanding: 14852991
Book value: 286188541.8125788
Debt to equity: 0.008075962997405902
Current ratio: 4.738479850365584
Quick ratio: 4.047100833191634
Retained earnings: 203109679.22678247
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 7925.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 273238871.8085817
Buffett classification: The Gruesome
Shares outstanding: 14852991
Book value: 277449538.831707
Debt to equity: 0.007949508575833495
Current ratio: 4.129815380142462
Quick ratio: 3.547608664050007
Retained earnings: 196725036.75979146
Capitalized R&D asset: 0
Rule of 40 score: 0